Literature DB >> 28369849

Hepatitis B virus infection is associated with younger median age at diagnosis and death in cancers.

Xiao-Li Wei1, Hui-Yan Luo1, Chao-Feng Li2, Ying Jin1, Zhao-Lei Zeng3, Huai-Qiang Ju3, Qi-Nian Wu1, Yun Wang1, Min-Jie Mao4, Wan-Li Liu4, Wei-Hua Jia3, Hui-Zhong Zhang5, Yu-Hong Li1, Feng Wang1, Rui-Hua Xu1.   

Abstract

Several non-hepatocellular cancers were linked with hepatitis B virus (HBV) infection. This study was aimed to quantify the potential associations between HBV infection and multiple non-hepatocellular cancers. Continuous cases, including 5,715 non-cancer and 40,963 cancer cases diagnosed from 2008 to 2014 in Sun Yat-sen University Cancer Center were analyzed. HBV DNA and hepatitis B core antigen (HBcAg) were examed in gastric cancer tissues by polymerase chain reaction and immunohistochemical staining. After adjusting for age, sex, year of diagnosis, smoking, drinking and family history of cancer, significant associations were found between serum HBsAg and frequently reported HBV-related non-hepatocellular cancers, including non-Hodgkin's lymphoma, cholangiocarcinoma and pancreatic cancer [adjusted odds ratio (AOR) and 95% confidence interval (CI): 1.89 (1.65-2.16)], as well as total other non-hepatocellular cancers [AOR and 95% CI: 1.12 (1.03-1.22)]. The median ages at diagnosis, all-cause death and cancer-specific death of serum HBsAg positive cancer patients were all significantly younger than those with serum HBsAg negative. HBV DNA was detected in 12.4% (34/275) gastric cancer tissues and HBcAg was most commonly detected in lymphocytes. This was the first report that HBV infection had a modest but significant nonspecific association with total non-hepatocellular cancers. Median age at diagnosis and death was significantly younger in serum HBsAg positive cancer patients. The underlying mechanism needs further investigation.
© 2017 UICC.

Entities:  

Keywords:  age; cancer; hepatitis B

Mesh:

Substances:

Year:  2017        PMID: 28369849     DOI: 10.1002/ijc.30719

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

Review 1.  Association between viral infection other than human papillomavirus and risk of esophageal carcinoma: a comprehensive meta-analysis of epidemiological studies.

Authors:  Hui Geng; Yaqi Xing; Jingbing Zhang; Kexin Cao; Meijie Ye; Geng Wang; Caixia Liu
Journal:  Arch Virol       Date:  2021-10-12       Impact factor: 2.574

2.  Development and validation of a prognostic nomogram in gastric cancer with hepatitis B virus infection.

Authors:  Yi He; Minjie Mao; Wenjuan Shi; Zhonglian He; Lin Zhang; Xueping Wang
Journal:  J Transl Med       Date:  2019-03-25       Impact factor: 5.531

3.  A case-control study of risk factors for hepatitis B infection: A regional report among Isfahanian adults.

Authors:  Behrooz Ataei; Sayed Moayed Alavian; Faramarz Shahriari-Fard; Abbas Ali Rabiei; Ali Safaei; Ali Rabiei; Mehdi Ataei
Journal:  J Res Med Sci       Date:  2019-03-25       Impact factor: 1.852

Review 4.  The microbiota and microbiome in pancreatic cancer: more influential than expected.

Authors:  Miao-Yan Wei; Si Shi; Chen Liang; Qing-Cai Meng; Jie Hua; Yi-Yin Zhang; Jiang Liu; Bo Zhang; Jin Xu; Xian-Jun Yu
Journal:  Mol Cancer       Date:  2019-05-20       Impact factor: 27.401

5.  Clinical, epidemiological aspects, and trends of Hepatitis B in Brazil from 2007 to 2018.

Authors:  Cathianne Sacramento Pinto; Galileu Barbosa Costa; Ivan Bezerra Allaman; Sandra Rocha Gadelha
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

Review 6.  Polyphenols as Promising Drugs against Main Breast Cancer Signatures.

Authors:  María Losada-Echeberría; María Herranz-López; Vicente Micol; Enrique Barrajón-Catalán
Journal:  Antioxidants (Basel)       Date:  2017-11-07

7.  Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control study.

Authors:  Jihyun An; Jong Woo Kim; Ju Hyun Shim; Seungbong Han; Chang Sik Yu; Jaewon Choe; Danbi Lee; Kang Mo Kim; Young-Suk Lim; Young-Hwa Chung; Yung Sang Lee; Dong Jin Suh; Jin Hyoung Kim; Han Chu Lee
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

8.  Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection.

Authors:  Seogsong Jeong; Bo Zheng; Jian Wang; Jiachang Chi; Ying Tong; Lei Xia; Ning Xu; Jianjun Zhang; Xiaoni Kong; Jinyang Gu; Qiang Xia
Journal:  Int J Biol Sci       Date:  2017-09-21       Impact factor: 6.580

9.  Chronic Hepatitis Virus Infection Are Associated With High Risk of Gastric Cancer: A Systematic Review and Cumulative Analysis.

Authors:  Yusha Yang; Zufu Jiang; Weizhou Wu; Libin Ruan; Chengyang Yu; Yuning Xi; Liling Wang; Kunpeng Wang; Jinggang Mo; Shankun Zhao
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

10.  Associations Between Gastric Cancer Risk and Virus Infection Other Than Epstein-Barr Virus: A Systematic Review and Meta-analysis Based on Epidemiological Studies.

Authors:  Hui Wang; Xiao-Long Chen; Kai Liu; Dan Bai; Wei-Han Zhang; Xin-Zu Chen; Jian-Kun Hu
Journal:  Clin Transl Gastroenterol       Date:  2020-07       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.